XML 51 R32.htm IDEA: XBRL DOCUMENT v3.24.3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
 12 Months Ended
Sep. 27, 2024
Accounting Policies [Abstract]  
Schedule of Restrictions on Cash and Cash Equivalents Cash and cash equivalents and restricted cash as reported within the Consolidated Statements of Cash Flows consisted of the following:
Twelve Months Ended September 27, 2024Twelve Months Ended September 29, 2023
(In millions)Beginning of PeriodEnd of PeriodBeginning of PeriodEnd of Period
Cash and cash equivalents$152.6 $168.7 $89.4 $152.6 
Restricted cash1.4 1.7 1.2 1.4 
Total as presented in the Consolidated Statements of Cash Flows$154.0 $170.4 $90.6 $154.0 
Schedule of Concentration of Risk, by Risk Factor During the periods presented, one of the Company's customers accounted for a significant portion of revenues, as set forth below:
Fiscal Years
202420232022
Canon Medical Systems Corporation
17.6 %16.5 %17.2 %
Schedule of Inventory, Net The following table summarizes the Company’s inventories, net:
(In millions)September 27, 2024September 29, 2023
Raw materials and parts$214.5 $217.5 
Work-in-process16.2 20.0 
Finished goods34.1 40.0 
Total inventories$264.8 $277.5 
Schedule of Property, Plant and Equipment, Net The following table summarizes the Company’s property, plant and equipment, net:
(In millions)September 27, 2024September 29, 2023
Land$8.6 $8.3 
Buildings and leasehold improvements165.5 159.1 
Machinery and equipment206.5 194.9 
Construction in progress25.0 20.8 
Gross property, plant and equipment405.6 383.1 
Accumulated depreciation and amortization(252.2)(239.5)
Total property, plant and equipment, net$153.4 $143.6 
Schedule of Supplier Finance Program
The following table presents the change in the direct supplier financing obligation:
Fiscal Years Ended
(In millions)September 27, 2024September 29, 2023
Confirmed obligations outstanding at the beginning of the period$4.2 $5.1 
Invoices confirmed during the period31.3 42.9 
Confirmed invoices paid during the period(32.9)(43.8)
Confirmed obligations outstanding at the end of the period$2.6 $4.2 
Schedule of Product Warranty Liability The following table reflects the changes in the Company’s accrued product warranty:
Fiscal Years Ended
(In millions)September 27, 2024September 29, 2023
Accrued product warranty, at beginning of period$7.7 $7.9 
New accruals charged to cost of revenues21.0 12.7 
Product warranty expenditures(17.9)(12.9)
Accrued product warranty, at end of period$10.8 $7.7